- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 24, 2024, 02:43:35 pm
- Local Time:
- June 17, 2024, 12:46:05 am
- Last Active:
- May 24, 2024, 04:38:19 pm
Signature:
3% and 40% when compared with 42.9% as well as 25% for ustekinumab, these kinds of differences are not in the past important. Ixekizumab achieved an i